• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX INC. AFX; BIFURCATED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX INC. AFX; BIFURCATED Back to Search Results
Model Number BA28-100/I16-40
Device Problems Failure To Adhere Or Bond (1031); Collapse (1099); Detachment Of Device Component (1104); Leak/Splash (1354); Torn Material (3024); Unintended Movement (3026)
Patient Problems Aneurysm (1708); Failure of Implant (1924)
Event Date 08/23/2016
Event Type  Injury  
Manufacturer Narrative
The devices involved in the event will not be returned for evaluation, they remain implanted in the patient.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.Devices remain implanted in the patient.
 
Event Description
Patient initially implanted with a bifurcated stent and a suprarenal aortic extension on (b)(6) 2014.A follow up computed tomography (ct) on (b)(6) 2016 showed a type 3a endoleak with component separation and aneurysm sac growth.The ct also identified the stent was kinked with a type 3b endoleak present.A subsequent endovascular procedure was completed on (b)(6) 2016.During the procedure the physician identified the material on the bifurcated stent was torn.The physician elected to reline the devices by implanting an ovation main body and two ovation limb extensions.The patient is stable.
 
Manufacturer Narrative
At the close of the complaint investigation, based on the patient data received, a clinical evaluation confirmed aneurysm sac growth, a type 3b endoleak and a type 3a endoleak with complete component separation and collapse of the main body stent.The root cause of the reported event is unknown.There is not enough information to determine the root cause of the reported event.The manufacturing evaluation did not reveal any issues or deviations that would explain the reported event.The manufacturing lot evaluation confirmed all devices met specifications prior to release.The event devices remain implanted in the patient and were not available for further evaluation.There have been no additional reported adverse events for this patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX
Type of Device
BIFURCATED
Manufacturer (Section D)
ENDOLOGIX INC.
2 musick
irvine CA 92618
Manufacturer Contact
tahereh sedighi
2 musick
irvine, CA 92618
9495984671
MDR Report Key5989403
MDR Text Key55988335
Report Number2031527-2016-00457
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 08/30/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/30/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/28/2016
Device Model NumberBA28-100/I16-40
Device Lot Number1053297-022
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/28/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/09/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
SUPRARENAL AORTA UNI-ILIAC- (B)(4)
Patient Outcome(s) Required Intervention;
Patient Age55 YR
-
-